Literature DB >> 28916114

[Scleritis and episcleritis].

E Héron1, T Bourcier2.   

Abstract

Episcleritis is generally a benign disease with a self-limited course, while scleritis is a severe ocular condition due to a risk of impaired vision in one-fifth of patients and its association with systemic diseases in one third of them. Infectious scleritis, representing 8 % of the etiologies, is mainly of herpetic origin (varicella zoster and herpes simplex viruses). A systemic autoimmune disease is observed in roughly 30 % of scleritis patients: inflammatory rheumatisms (15 %), firstly rheumatoid polyarthritis, systemic vasculitides (8 %), mainly granulomatosis with polyangiitis (Wegener's) and polychondritis, and less often inflammatory bowel disease and systemic lupus erythematosus. Among the different types of scleritis, a clear distinction exists between necrotizing forms leading to decreased vision in 50 % of the cases and associated with systemic diseases in the vast majority, and non-necrotizing forms (either diffuse or nodular), with a better prognosis. However, recent publications show that necrotizing forms are much less frequent nowadays (around 5 % of the total), probably due to therapeutic innovations and progress made during the last 20 years. The medical management of scleritis requires collaboration between ophthalmologists and internists (or rheumatologists).
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Complication; Episcleritis; Infection; Maladie systémique; Scleritis; Sclérite; Systemic disease; Traitement; Treatment; Épisclérite

Mesh:

Year:  2017        PMID: 28916114     DOI: 10.1016/j.jfo.2017.04.007

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  2 in total

Review 1.  Do Oral Pathogens Inhabit the Eye and Play a Role in Ocular Diseases?

Authors:  Pachiappan Arjunan; Radhika Swaminathan
Journal:  J Clin Med       Date:  2022-05-23       Impact factor: 4.964

Review 2.  Management of noninfectious scleritis.

Authors:  Ahmad Abdel-Aty; Akash Gupta; Lucian Del Priore; Ninani Kombo
Journal:  Ther Adv Ophthalmol       Date:  2022-01-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.